Ginkgo Biloba: What Decades of Trials Concluded

What follows is what the evidence actually supports, and where it stops.

What this actually means

Ginkgo biloba is among the most heavily studied botanicals for cognition, with large trials producing largely disappointing results for preventing cognitive decline in healthy older adults. That definition matters because the term gets used loosely in supplement marketing, where a real mechanism is routinely stretched into a promise the evidence does not carry.

Its history is a useful lesson: an ingredient can be popular, plausible and extensively researched, and still not deliver.

Why it matters if you are buying a supplement

Almost every purchase decision in this category comes down to one question: is the product addressing the actual cause of the problem you have? Appetite, sleep debt, an energy surplus, insulin resistance and simple measurement error all produce similar-looking frustration, and they need different responses. Getting the cause right is worth more than getting the product right.

Its history is a useful lesson: an ingredient can be popular, plausible and extensively researched, and still not deliver. That is why the sequence on this site is always the same — understand the mechanism, check the dose against the research, then decide whether a product is buying you anything.

Four things worth knowing

• Large prevention trials did not show meaningful protection against cognitive decline.
• Some smaller studies suggest modest effects in specific clinical populations.
• Standardised extract at 120 to 240 mg daily is the usual studied range.
• It has anticoagulant potential and interacts with blood thinners.

What to do about it

1. Do not assume popularity indicates efficacy.
2. Check for interaction with any blood-thinning medication.
3. Stop before surgery due to bleeding risk.
4. Judge products on the whole formula rather than one familiar name.

None of those cost anything, which is the point. In cognitive health the interventions with the strongest evidence — treating blood pressure and hearing loss, seven hours of sleep, aerobic exercise, staying socially engaged and reviewing sedating medications — are consistently cheaper and far less marketed than the ones with the weakest.

One more framing point. Effect sizes in this field are usually small, and small effects are exactly the ones personal impression cannot detect — especially for cognition, where how sharp you feel tracks last night's sleep more than anything else. A written baseline beats a feeling every time.

The myth to drop

That ginkgo is a proven memory treatment. The largest prevention trials did not support that.

For background reading from sources with nothing to sell, see NIH ODS — supplements for exercise and performance and National Institute on Aging — memory loss and forgetfulness.

Where MemoHoney fits

MemoHoney official website is a once-daily capsule whose Supplement Facts panel lists seven items: Niacin 7.5 mg NE (47% of the Daily Value), Calcium as calcium carbonate 18 mg, L-Arginine base 200 mg, L-Arginine AKG 2:1 Extract 200 mg, L-Citrulline HCl 100 mg, L-Citrulline Malate 100 mg and Beta-Alanine 40 mg. Every amount is printed, which is more than the two largest pages selling it will tell you.

Read against this topic, the honest placement is as a background nutritional layer rather than a solution. Niacin is delivered at a sensible amount. The amino acids are not: after salt-form conversion the capsule supplies roughly 315 mg of free arginine and 140 mg of free citrulline, against research intakes around 3,000 mg each. And none of the ingredients with human evidence for memory — bacopa, ginkgo, citicoline, Alpha-GPC, phosphatidylserine — appear on the panel at all. It belongs underneath sleep, blood pressure control, hearing checks and exercise, not in place of them. The detail is on the MemoHoney ingredient and dose analysis.

Questions readers ask